Cargando…

Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gel

BACKGROUND: In a recent placebo-controlled Phase III study, oxybutynin chloride topical gel (OTG) significantly improved urinary continence in patients with overactive bladder. In this post hoc analysis, the effect of incontinence severity on OTG-mediated improvement in continence was evaluated. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sand, Peter K, MacDiarmid, Scott A, Thomas, Heather, Caramelli, Kim E, Hoel, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818944/ https://www.ncbi.nlm.nih.gov/pubmed/24198648 http://dx.doi.org/10.2147/OAJU.S24199

Ejemplares similares

Development of oxybutynin chloride topical gel for overactive bladder
por: Lucente, Vincent R, et al.
Publicado: (2011)

Oxybutynin topical gel in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2010)

Topical Oxybutynin 3% Gel Versus Aluminum Chloride 15% Lotion in Treatment of Primary Focal Hyperhidrosis
por: El-Agamy El-Samadony, Amany, et al.
Publicado: (2023)

Atypical aquagenic keratoderma treated with oxybutynin chloride
por: Dixit, Niharika, et al.
Publicado: (2018)

Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin
por: Gamble, Tondalaya, et al.
Publicado: (2008)

Long-Term Efficacy, Safety, and Tolerability of Modified Intravesical Oxybutynin Chloride for Neurogenic Bladder in Children
por: Honda, Masashi, et al.
Publicado: (2019)

Oxybutynin: an overview of the available formulations
por: McCrery, Rebecca J, et al.
Publicado: (2006)

Oxybutynin as an alternative treatment for hyperhidrosis
por: Delort, Sergio, et al.
Publicado: (2017)

Efficacy, Safety and Quality of Life of Oxybutynin versus Aluminum Chloride Hexahydrate in Treating Primary Palmar Hyperhidrosis
por: Attallah, Heba Shawky, et al.
Publicado: (2022)

Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006)

Methadone-Induced Hyperhidrosis Treated With Oxybutynin
por: Hong, Joe, et al.
Publicado: (2017)

Clinical utility of transdermal delivery of oxybutynin gel via a metered-dose pump in the management of overactive bladder
por: Wagg, Adrian
Publicado: (2012)

Efficacy, Tolerability, and Safety of Oxybutynin Chloride in Pediatric Neurogenic Bladder With Spinal Dysraphism: A Retrospective, Multicenter, Observational Study
por: Lee, Jung Hoon, et al.
Publicado: (2014)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin
por: Kamikava, Débora Yumi Ferreira, et al.
Publicado: (2021)

Factorial design-assisted spectroscopic determination of oxybutynin hydrochloride
por: Yosrey, Eman, et al.
Publicado: (2021)

Oxybutynin-Induced Hyperthermia in a Patient With Parkinson’s Disease
por: Ahmad, Saad, et al.
Publicado: (2021)

Bacterial minicells to the rescue: cyto‐Immunotherapy for the treatment of late stage cancers with minimal to no toxicity
por: Brahmbhatt, Himanshu, et al.
Publicado: (2021)

Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms
por: Maldonado-Avila, Miguel, et al.
Publicado: (2016)

Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome management
por: Turell, Wendy, et al.
Publicado: (2020)

A Novel Metered Dose Transdermal Spray Formulation for Oxybutynin
por: Bakshi, A., et al.
Publicado: (2008)

Long-term results of oxybutynin use in treating facial hyperhidrosis
por: Wolosker, Nelson, et al.
Publicado: (2014)

A case of probable oxybutynin-induced increase in liver enzymes
por: Alrawashdeh, Haneen, et al.
Publicado: (2018)

Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens
por: Katsuki, Masahito
Publicado: (2023)

A Novel Totivirus Naturally Occurring in Two Different Fungal Genera
por: Khalifa, Mahmoud E., et al.
Publicado: (2019)

A Mechanically Transmitted DNA Mycovirus Is Targeted by the Defence Machinery of Its Host, Botrytis cinerea
por: Khalifa, Mahmoud E., et al.
Publicado: (2021)

Molecular Characterization of Two Totiviruses from the Commensal Yeast Geotrichum candidum
por: Khalifa, Mahmoud E., et al.
Publicado: (2023)

A 29-year-old woman with recurrent syncope
por: Ducas-Mowchun, Kaleigh, et al.
Publicado: (2023)

Une femme de 29 ans atteinte d’épisodes répétitifs de syncope
por: Ducas-Mowchun, Kaleigh, et al.
Publicado: (2023)

Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility
por: Schweitzer, Paula K., et al.
Publicado: (2022)

Oxybutynin extended release for the management of overactive bladder: a clinical review
por: Arisco, AM, et al.
Publicado: (2009)

Oxybutynin and Tolterodine in a Trial for Treatment of Overactive Bladder in Iranian Women
por: Aziminekoo, Elham, et al.
Publicado: (2014)

Analysis of oxybutynin treatment for hyperhidrosis in patients aged over 40 years
por: Wolosker, Nelson, et al.
Publicado: (2014)

Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
por: Vozmediano-Chicharro, Raúl, et al.
Publicado: (2020)

Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
por: Crespo, Carlos, et al.
Publicado: (2018)

Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder
por: Cardozo, Linda, et al.
Publicado: (2014)

Randomized trial - oxybutynin for treatment of persistent plantar hyperhidrosis in women after sympathectomy
por: da Silva Costa, Altair, et al.
Publicado: (2014)

Intravesical Oxybutynin for Urgent Bladder Rescue in a Newborn with Posterior Urethral Valves
por: Molina Caballero, Ada, et al.
Publicado: (2019)

Grapevine Leafroll-Associated Virus 3 Genotype Influences Foliar Symptom Development in New Zealand Vineyards
por: Chooi, Kar Mun, et al.
Publicado: (2022)

Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool
por: Bates, David, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f2qdfkua8fh7bv7p2oiisickur